Sort
15,273 grants matching “antimicrobial resistance”
Pharmacokinetic-Pharmacodynamics of Antimicrobials in Resistant Infections
$128,250Jennifer Le · University Of California, San Diego · K23 · FY2011 · AI
Chlorhexidine and Pneumonia in Nursing Home Residents
$128,250Catherine J Binkley · University Of Louisville · K23 · FY2008 · DE
Metabolomics Evaluation of the Etiology of Pneumonia
$128,250Lilliam Ambroggio · University Of Colorado Denver · K01 · FY2019 · AI
Device use in Nursing Homes: Reducing Risk of Infection
$128,250University Of Michigan At Ann Arbor · K23 · FY2005 · AG
Metabolomics Evaluation of the Etiology of Pneumonia
$128,250Lilliam Ambroggio · University Of Colorado Denver · K01 · FY2020 · AI
Metabolomics Evaluation of the Etiology of Pneumonia
$128,250Lilliam Ambroggio · Cincinnati Childrens Hosp Med Ctr · K01 · FY2017 · AI
Pharmacokinetic-Pharmacodynamics of Antimicrobials in Resistant Infections
$128,250Jennifer Le · University Of California, San Diego · K23 · FY2012 · AI
Drug-Drug Interactions between Pharmaceutical and Endogenous Antibiotics
$128,126George Sakoulas · University Of California, San Diego · U54 · FY2014 · HD
Defining Precursors to VRSA Emergence: Epidemiology of MRSA & VRE Dual Infection
$128,025Emily Toth Martin · University Of Michigan At Ann Arbor · K01 · FY2016 · AI
Role of Immunogenetic Determinants on Human Genital Chlamydial Infection
$127,764William M Geisler · University Of Alabama At Birmingham · K23 · FY2008 · AI
Role of Immunogenetic Determinants on Human Genital Chlamydial Infection
$127,764William M Geisler · University Of Alabama At Birmingham · K23 · FY2007 · AI
Role of Immunogenetic Determinants on Human Genital Chlamydial Infection
$127,764William M Geisler · University Of Alabama At Birmingham · K23 · FY2011 · AI
Role of Immunogenetic Determinants on Human Genital Chlamydial Infection
$127,764William M Geisler · University Of Alabama At Birmingham · K23 · FY2009 · AI
Role of Immunogenetic Determinants on Human Genital Chlamydial Infection
$127,764William M Geisler · University Of Alabama At Birmingham · K23 · FY2010 · AI
Characterizing novel Beta-lactamases from metagenomic samples: insights into the evolution of antimicrobial resistance from the environment towards human-associated pathogens
$127,728Pablo Power · Ubatec S.A. · R01 · FY2022 · AI
Investigating the dynamics of Salmonella Typhi and bacteriophages in the environment and the human gut
$127,709Senjuti Saha · Child Health Research Foundation · R01 · FY2025 · AI
DETERMINE EFFECT OF ANTIMICROBIAL OLIGOMERS ON BACTERIAL AND EUKARYOTIC CELLS
$127,681Annelise Barron · University Of California, San Francisco · P41 · FY2009 · RR
Effects of Probiotics in Patients with Cystic Fibrosis
$127,652Patricia L Hibberd · Tufts Medical Center · U01 · FY2009 · AT
DEALING WITH ANTIBIOTIC RESISTANCE--ANTISENSE TECHNOLOGY
$127,516California State University Fullerton · R15 · FY2000 · AI
NER: Biomimetic Platform for Probing Efficacy of Antimicrobial Agents
$127,500Regina Ragan · University Of California-Irvine · · FY2007 · ENG
Equipment Supplement request for a BD LSR Fortessa Flow Cytometer
$127,430David L. Williams · East Tennessee State University · R01 · FY2016 · GM
Systemic immunity induced by mucosal CD18+ cells
$127,370University Of Colorado Denver · K01 · FY2002 · RR
co-Trimoxazole in Zambian Infants (TZI)
$127,359Christopher J Gill · Boston University Medical Campus · K23 · FY2007 · AI
Characterizing novel Beta-lactamases from metagenomic samples: insights into the evolution of antimicrobial resistance from the environment towards human-associated pathogens
$127,235Pablo Power · Ubatec S.A. · R01 · FY2025 · AI
Campylobacter jejuni and Reactive Nitrogen Species
$127,224New York University School Of Medicine · K08 · FY2005 · AI